RIGEL PHARMACEUTICALS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2021-11-02: Form 10-Q; Exhibit 10.1; Description Rigel Pharmaceuticals, Inc. Inducement Plan, as amended.
- 2021-08-03: Form 10-Q; Exhibit 10.2; Description Rigel Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan, as amended..
- 2021-08-03: Form 10-Q; Exhibit 10.1; Description Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended..
- 2021-05-05: Form 10-Q; Exhibit 10.2; Description Non-employee Directors’ Compensation Policy.
| Filed | Form | Exhibit | Description |
|---|
| 2021-11-02 | 10-Q | 10.1 | Rigel Pharmaceuticals, Inc. Inducement Plan, as amended |
|---|
| 2021-08-03 | 10-Q | 10.2 | Rigel Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan, as amended. |
|---|
| 2021-08-03 | 10-Q | 10.1 | Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended. |
|---|
| 2021-05-05 | 10-Q | 10.2 | Non-employee Directors’ Compensation Policy |
|---|
| 2021-05-05 | 10-Q | 10.1 | License and Collaboration Agreement by and between the Company and Eli Lilly and Company, dated February 28, 2021. |
|---|
| 2021-02-03 | 8-K | 10.1 | 2021 Cash Incentive Plan |
|---|